Maxigen Biotech Inc.(TW:1783)
NT$36.00+0.75 (+2.13%)
TW:1783
Maxigen Biotech Inc. financials statements
NT$36.00
At close:+0.75 (+2.13%)
Maxigen Biotech Inc. (1783) Financial Statements
Maxigen Biotech Inc. Financial Overview
Maxigen Biotech Inc.'s market cap is currently NT$3.16B. The company's EPS TTM is NT$3.84; its P/E ratio is 9.38; and it has a dividend yield of 5.55%. Maxigen Biotech Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 811.56M | NT$ 680.65M | NT$ 622.12M | NT$ 604.43M | NT$ 511.98M |
| Gross Profit | NT$ 563.72M | NT$ 483.32M | NT$ 424.09M | NT$ 373.99M | NT$ 261.03M |
| Operating Income | NT$ 261.04M | NT$ 194.38M | NT$ 149.85M | NT$ 170.56M | NT$ 100.69M |
| EBITDA | NT$ 293.18M | NT$ 221.40M | NT$ 177.09M | NT$ 195.43M | NT$ 130.56M |
| Net Income | NT$ 265.31M | NT$ 190.17M | NT$ 165.83M | NT$ 139.40M | NT$ 87.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 877.69M | NT$ 640.55M | NT$ 432.58M | NT$ 801.26M | NT$ 540.18M |
| Total Assets | NT$ 1.89B | NT$ 1.58B | NT$ 1.49B | NT$ 1.45B | NT$ 1.27B |
| Total Debt | NT$ 101.40M | NT$ 0.00 | NT$ 50.00K | NT$ 0.00 | NT$ 9.74M |
| Net Debt | NT$ -474.79M | NT$ -639.05M | NT$ -431.03M | NT$ -790.95M | NT$ -503.56M |
| Total Liabilities | NT$ 355.54M | NT$ 207.36M | NT$ 131.88M | NT$ 152.07M | NT$ 123.47M |
| Stockholders' Equity | NT$ 1.54B | NT$ 1.38B | NT$ 1.36B | NT$ 1.30B | NT$ 1.14B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 207.59M | NT$ 266.45M | NT$ 148.76M | NT$ 253.90M | NT$ 102.15M |
| Operating Cash Flow | NT$ 290.22M | NT$ 298.22M | NT$ 171.20M | NT$ 268.34M | NT$ 117.59M |
| Investing Cash Flow | NT$ -382.99M | NT$ -29.07M | NT$ -490.25M | NT$ 10.43M | NT$ -2.77M |
| Financing Cash Flow | NT$ 30.66M | NT$ -59.73M | NT$ -41.39M | NT$ -1.05M | NT$ 188.69M |
Currency in TWD
